Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(E)-3-[2,6-Dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]-thiazol-2-ylcarbamoyl]-phenyl]-2-methylacrylic acid----1件: 63 💬
2(E)-3-[2,6-Dichloro-4-[4-[3-[(S)-1-hexyloxyethyl]-2-methoxyphenyl]-thiazol-2-ylcarbamoyl]-phenyl]-2methylacrylic acid----1件: 63 💬
310-mg dose of E5501 2G tablet----1件: 63 💬
410-mg dose of E5501 cyclodextrin oral solution----1件: 63 💬
510-mg dose of E5501 lipid-based oral----1件: 63 💬
610-mg dose of E5501-P21% powder----1件: 63 💬
75% (5g/100 ml) intravenous immunoglobin----1件: 63 💬
8[acetominofene]----2件: 11, 63 💬
9[ARGX-113]----3件: 11, 35, 63 💬
10[ETB115]----2件: 60, 63 💬
11[IMP-2]----1件: 63 💬
12[NA]----34件: 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
13[PRN1008]----2件: 35, 63 💬
14[Romiplostim]1件: Romiplostim1件: Romiplostim 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
15[TAK-079]----1件: 63 💬
16[UCB7665 ]----1件: 63 💬
17[UCB7665]1件: Rozanolixizumab1件: Rozanolixizumab 💬 --2件: 11, 63 💬
18[VAY736]----4件: 49, 53, 61, 63 💬
19Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
20Acetaminophen and Diphenhydramine Only Product2件: Acetaminophen,
Diphenhydramine		5件: Acetaminophen ,
Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		3件: HRH1,
PTGS1,
PTGS2 💬 		27件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 63 💬
21Acetate1件: Acetate---52件: 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
22Acetominophen----1件: 63 💬
23Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬 --25件: 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
24Acide acétylsalicylique----1件: 63 💬
25ACT-HIB Polvere e solvente per soluzione iniettabile in siringa preriempita 0,5 ml----4件: 61, 62, 63, 223 💬
26Adenine1件: Adenine1件: Adenine 💬 --1件: 63 💬
27AKR-501, YM-477----1件: 63 💬
28ALEMTUZUMAB1件: Alemtuzumab1件: Alemtuzumab 💬 --21件: 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
29Alemtuzumab, Rituximab2件: Alemtuzumab,
Rituximab		2件: Alemtuzumab ,
Rituximab 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
30All trans retinoic acid----1件: 63 💬
31All-trans retinoic acid----2件: 63, 94 💬
32All-trans retinoic acid (ATRA)----1件: 63 💬
33All-Trans Retinoid Acid(ATRA)----1件: 63 💬
34All-trans-retinoid acid----1件: 63 💬
35AMG 531----1件: 63 💬
36AMG531----2件: 60, 63 💬
37Amifostine1件: Amifostine2件: Amifostine ,
Amifostine 💬 		--2件: 28, 63 💬
38Aminophylline1件: Aminophylline2件: Aminophylline ,
Aminophylline dihydrate 💬 		18件: ADORA1,
ADORA2B,
PDE10A,
PDE11A,
PDE1A,
PDE1B,
PDE1C,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE7A,
PDE7B,
PDE8A,
PDE8B 💬 		23件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 63 💬
39Amoxicillin1件: Amoxicillin3件: Amoxicillin ,
Amoxicillin sodium ,
Amoxicillin 💬 		--9件: 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
40Amoxicillin 50 mg/kg/day in 2 divided doses for 14 days.1件: Amoxicillin3件: Amoxicillin ,
Amoxicillin sodium ,
Amoxicillin 💬 		--1件: 63 💬
41Amoxicillin hydrate1件: Amoxicillin3件: Amoxicillin ,
Amoxicillin sodium ,
Amoxicillin 💬 		--1件: 63 💬
42Anti-CD19 CAR NK cells (KN5501)----2件: 49, 63 💬
43Anti-CD19/BCMA CAR gene vector injection will be injected intravenously on a one-time basis.----1件: 63 💬
44Anti-CD20 monoclonal antibody and the BTK inhibitor----2件: 61, 63 💬
45Anti-CD38 antibody Injection----3件: 48, 61, 63 💬
46Anti-CD40L----1件: 63 💬
47Anti-CD40LdAb----1件: 63 💬
48Anti-D----1件: 63 💬
49Anti-Thymocyte Globulin----19件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
50Antox tablets(Mepaco)----1件: 63 💬
51Aprednisolon----1件: 63 💬
52ARGX-113----5件: 11, 14, 35, 53, 63 💬
53Aspirin1件: Acetylsalicylic acid1件: Aspirin 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬10件: 22, 34, 48, 49, 51, 63, 86, 158, 210, 231 💬
54Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬21件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
55Atorvastatin 10mg1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 63 💬
56Atorvastatin 20mg1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 63 💬
57Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet2件: Acetylcysteine,
Atorvastatin		3件: Acetylcysteine ,
Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬1件: 63 💬
58ATRA----1件: 63 💬
59Autologous anti-BCMA chimeric antigen receptor T cells----1件: 63 💬
60Autologous peripheral blood stem cell transplantation----9件: 28, 40, 41, 42, 45, 46, 49, 63, 283 💬
61Avatrombopag1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
62Avatrombopag (proposed)1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
63Avatrombopag 20 MG Oral Tablet1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
64AVATROMBOPAG MALEATE1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
65Avatrombopag Oral Tablet1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
66Avatrombopag tablets1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
67Avatrombopag+All trans retinoic acid1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
68Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬 		--26件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
69B02BX05----1件: 63 💬
70Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬24件: 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
71Baricitinib 2 MG1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬3件: 46, 53, 63 💬
72Baricitinib 2 MG [Olumiant]1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬2件: 63, 162 💬
73BCMA-CD19 cCAR T cells----1件: 63 💬
74Belantamab mafodotin1件: Belantamab mafodotin1件: Belantamab mafodotin 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬2件: 28, 63 💬
75BELIMUMAB1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬17件: 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
76Benlysta----7件: 43, 48, 49, 53, 63, 66, 222 💬
77BENLYSTA® (belimumab)1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 11, 63, 66, 222 💬
78BEXSERO – Sospensione iniettabile – Siringa preriempita----4件: 61, 62, 63, 223 💬
79BI 655064----2件: 46, 63 💬
80Biological tests----1件: 63 💬
81Biological: M254----1件: 63 💬
82BIVV009 6.5 grams----1件: 63 💬
83BIVV009 7.5 grams----1件: 63 💬
84BIVV020----3件: 14, 61, 63 💬
85Blinded (Avatrombopoag tablets)----1件: 63 💬
86Blisibimod1件: Blisibimod1件: Blisibimod 💬 --5件: 43, 44, 49, 63, 66 💬
87Blood sample----33件: 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
88Blood samples----14件: 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
89BMS-986004----1件: 63 💬
90BMS-986004 1500 mg IV----1件: 63 💬
91BMS-986004 225 mg IV----1件: 63 💬
92BMS-986004 675 mg IV----1件: 63 💬
93BMS-986004 75 mg IV----1件: 63 💬
94BMS-986353----3件: 51, 61, 63 💬
95BMS-986413----2件: 63, 64 💬
96BMS-986414----2件: 63, 64 💬
97BORTEZOMIB1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬19件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
98BT595----2件: 63, 65 💬
99Bu Zhong Yi Qi Tang, Zhi Xue Tang, Chuan xin lian kang yan pian mod, Tian Wang Bu xin Dan----1件: 63 💬
100Budoprutug1件: Budoprutug---3件: 49, 63, 222 💬
101Bélimumab----1件: 63 💬
102Caffeic acid----1件: 63 💬
103Caffeic acid tablets----1件: 63 💬
104Caplacizumab1件: Caplacizumab1件: Caplacizumab 💬 1件: VWF 💬 9件: Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬2件: 63, 64 💬
105CAR-T cells----1件: 63 💬
106CART Infusion----2件: 61, 63 💬
107CC312----5件: 46, 49, 51, 61, 63 💬
108CD19 UCAR-T cells----5件: 48, 49, 51, 53, 63 💬
109CD19/CD22/BCMA CAR-T cells(BZE2204)----2件: 49, 63 💬
110CD4-IgG----1件: 63 💬
111Cevidoplenib1件: Cevidoplenib---2件: 46, 63 💬
112Chidamide----1件: 63 💬
113CID-103----1件: 63 💬
114Clarithromycin1件: Clarithromycin1件: Clarithromycin 💬 --10件: 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
115Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days.1件: Clarithromycin1件: Clarithromycin 💬 --1件: 63 💬
116CM313 injection----3件: 35, 49, 63 💬
117CM336 Injection----2件: 61, 63 💬
118CNCT19 cell injection----2件: 49, 63 💬
119Collection of biological samples----1件: 63 💬
120Combination of Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
121Combination of Rituximab with subcutaneous belimumab2件: Belimumab,
Rituximab		2件: Rituximab ,
Belimumab 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
122Combination Product: Ripertamab/Eltrombopag2件: Eltrombopag,
Ripertamab		2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
123Combined use of TPO-RAs with low-dose anti-CD20 antibody----1件: 63 💬
124Conventional----1件: 63 💬
125Corticosteriod for treated patients----1件: 63 💬
126Corticosteroids----13件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
127Corticosteroids (Aprednislon)----1件: 63 💬
128Corticosteroids combined with immunoglobulin and romiplostim1件: Romiplostim1件: Romiplostim 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
129CTX112----3件: 51, 61, 63 💬
130Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
131Cyclosporin A----12件: 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
132Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
133Cytokine essays----2件: 61, 63 💬
134DACLIZUMAB1件: Daclizumab1件: Daclizumab 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬10件: 13, 26, 56, 60, 63, 65, 97, 107, 283, 284 💬
135Danazol1件: Danazol1件: Danazol 💬 3件: AR,
ESR1,
PGR 💬 		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬5件: 60, 63, 64, 65, 285 💬
136Dapsone1件: Dapsone1件: Dapsone 💬 --6件: 35, 42, 60, 63, 84, 162 💬
137Dapsone (Disulone®)1件: Dapsone1件: Dapsone 💬 --1件: 63 💬
138Daratumumab1件: Daratumumab1件: Daratumumab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬13件: 13, 16, 28, 39, 46, 48, 49, 60, 63, 222, 223, 288, 331 💬
139Daratumumab Injection1件: Daratumumab1件: Daratumumab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬4件: 16, 28, 49, 63 💬
140Daratumumab(Anti-CD38 Monoclonal Antibody)1件: Daratumumab1件: Daratumumab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 63 💬
141Darzalex----3件: 28, 49, 63 💬
142Decitabine1件: Decitabine1件: Decitabine 💬 3件: DNMT1,
DNMT3A,
DNMT3B 💬 		3件: Cysteine and methionine metabolism, Efferocytosis, MicroRNAs in cancer 💬2件: 60, 63 💬
143DESAMETASONE----3件: 28, 63, 90 💬
144Desametasone 40mg----1件: 63 💬
145DEX Combined With RTX, CSA and IVIG----1件: 63 💬
146Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
147Dexamethasone (1 cycle)1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
148Dexamethasone (4 cycles)1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
149Dexamethasone Abcur1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
150DEXAMETHASONE ACETATE3件: Acetate,
Dexamethasone,
Dexamethasone acetate		5件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone acetate ,
Dexamethasone 21-acetate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
151Dexamethasone and Rituximab2件: Dexamethasone,
Rituximab		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Rituximab ,
Dexamethasone phosphate 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
152Dexamethasone Combined with romiplostim N012件: Dexamethasone,
Romiplostim		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		2件: MPL,
NR3C1 💬 		4件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63 💬
153Dexamethasone monotherapy1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
154Dexamethasone oral1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
155Dexamethasone palmitate2件: Dexamethasone,
Dexamethasone palmitate		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone palmitate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
156Dexamethasone USP Micronized1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
157DIACEREIN1件: Diacerein1件: Diacerein 💬 --3件: 36, 46, 63 💬
158Diagnostic Test: complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-?.----1件: 63 💬
159Diagnostic Test: complete blood picture----1件: 63 💬
160Diagnostic Test: estimation of serum level of IL17----1件: 63 💬
161Diagnostic Test: estimation of serum level of IL2----1件: 63 💬
162Diagnostic Test: Laboratory test----1件: 63 💬
163Diagnostic Test: Lactate dehydrogenase----1件: 63 💬
164Diagnostic Test: Plasma RNA isolation, qPCR analysis of micro RNA----1件: 63 💬
165Diagnostic Test: Quantitative microbiological test for HCV----1件: 63 💬
166Diagnostic Test: Search for thyroid disorders----1件: 63 💬
167Diagnostic Test: Serological assay for blood born viral hepatitis----1件: 63 💬
168Diagnostic Test: Serum IL10 By ELISA----1件: 63 💬
169Diagnostic Test: serum interleukin 10 level----1件: 63 💬
170Diagnostic Test: SNP -3279 A/C of FOXP3----1件: 63 💬
171Diagnostic Test: SNP-924 A/G Of FOXP3----1件: 63 💬
172Diammonium glycyrrhizinate enteric-coated capsule----1件: 63 💬
173Difenidramina----2件: 11, 63 💬
174DIFENIDRAMINA CLORIDRATO----3件: 11, 19, 63 💬
175Diphenhydramine1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬12件: 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
176Discontinuation of eltrombopag1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
177Doptelet 20 mg film-coated tablets----1件: 63 💬
178Doxil----1件: 63 💬
179Dyphenhydramine hydrochloride----1件: 63 💬
180DZD8586 dose level 1----1件: 63 💬
181DZD8586 dose level 2----1件: 63 💬
182DZD8586 dose level 3----1件: 63 💬
183E5501----1件: 63 💬
184E5501 40 mg 2 x 20-mg tablets, orally, fasted----1件: 63 💬
185E5501 40 mg 2 x 20-mg tablets, orally, with food----1件: 63 💬
186E5501 40mg 2 x 20-mg tablets, orally, fasted----1件: 63 💬
187Efgartigimod1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --8件: 11, 14, 35, 36, 53, 63, 64, 300 💬
188EFGARTIGIMOD ALFA1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --7件: 11, 13, 14, 35, 53, 63, 162 💬
189Efgartigimod alpha----1件: 63 💬
190Efgartigimod IV1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --3件: 11, 63, 222 💬
191Efgartigimod PH20 SC1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --7件: 11, 14, 35, 50, 53, 63, 162 💬
192ELTROMBOPAG1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬5件: 60, 63, 65, 284, 285 💬
193Eltrombopag (Revolade)1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
194Eltrombopag (Revolade®)1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
195Eltrombopag 25 mg1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
196Eltrombopag and dexamethasone2件: Dexamethasone,
Eltrombopag		5件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Eltrombopag olamine ,
Dexamethasone phosphate ,
Eltrombopag choline 💬 		2件: MPL,
NR3C1 💬 		4件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63 💬
197Eltrombopag and romiplastim1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
198Eltrombopag combining rituximab2件: Eltrombopag,
Rituximab		3件: Rituximab ,
Eltrombopag olamine ,
Eltrombopag choline 💬 		2件: MPL,
MS4A1 💬 		4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
199ELTROMBOPAG OLAMINE1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
200Eltrombopag olamine (SB-497115-GR)1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
201Eltrombopag olamine, Revolade, Promacta1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
202Eltrombopag oral tablets1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
203Eltrombopag PfOS1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
204Eltrombopag plus diacerein2件: Diacerein,
Eltrombopag		3件: Eltrombopag olamine ,
Diacerein ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
205ERYTHROPOIETIN1件: Erythropoietin4件: Epoetin alfa ,
Epoetin epsilon ,
Epoetin theta ,
Epoetin zeta 💬 		1件: EPOR 💬 7件: Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬11件: 2, 6, 13, 18, 22, 47, 61, 63, 70, 95, 96 💬
206ESG206----2件: 53, 63 💬
207ETB115----2件: 60, 63 💬
208Ethanolamine1件: Ethanolamine1件: Monoethanolamine 💬 --3件: 60, 63, 279 💬
209Fecal microbiome----2件: 61, 63 💬
210Fecal microbiota1件: Fecal microbiota---14件: 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
211Fecal microbiota transplantation1件: Fecal microbiota---9件: 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
212Filgrastim1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬30件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
213Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
214Fludarabine phosphate1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬14件: 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
215Fostamatinib1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬5件: 46, 49, 61, 63, 66 💬
216Fostamatinib Disodium1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬4件: 46, 61, 63, 66 💬
217Fostamatinib Disodium / R9357881件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
218Fostamatinib disodium 100 mg1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
219Fostamatinib disodium 150 mg1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
220Fostamatinib disodium tablets1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬 		1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 63 💬
221G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬12件: 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
222Gammaplex----2件: 63, 65 💬
223Gammaplex, intravenous immunoglobulin----1件: 63 💬
224Genetic: CD19 and BCMA-targeted allogeneic CAR-T cells----1件: 63 💬
225Genetic: Global DNA methylation will be quantified in the DNA samples by colorimetry----1件: 63 💬
226GL-20451件: GL-2045---1件: 63 💬
227Glycyrrhetinic Acid----1件: 63 💬
228GMA161----1件: 63 💬
229GNR-069----1件: 63 💬
230Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
231GP404141----1件: 63 💬
232GSK1550188----5件: 11, 49, 63, 66, 222 💬
233H. pylori triple therapy----1件: 63 💬
234HAEMOPHILUS INFLUENZAE----5件: 61, 62, 63, 66, 223 💬
235HBM9161 Dose A----1件: 63 💬
236HBM9161 Dose B----1件: 63 💬
237HD-DXM----1件: 63 💬
238Herombopag----2件: 60, 63 💬
239Herombopag olamine tablets----1件: 63 💬
240Hetrombopag1件: Hetrombopag---2件: 60, 63 💬
241Hetrombopag 5mg po qd1件: Hetrombopag---1件: 63 💬
242Hetrombopag Olamine1件: Hetrombopag---2件: 60, 63 💬
243HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML----5件: 61, 62, 63, 66, 223 💬
244High dose dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
245High dose Dexamethasone pulses1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
246High-dose Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
247High-Dose Dexamethasone Combined1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
248High-Dose Dexamethasone Combined with Orelabrutinib2件: Dexamethasone,
Orelabrutinib		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Orelabrutinib 💬 		2件: BTK,
NR3C1 💬 		8件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
249Higher Dose of Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
250HMPL-523----2件: 46, 63 💬
251Honey1件: Honey1件: Honey 💬 --4件: 57, 63, 98, 230 💬
252Huaiqihuang Granule----2件: 63, 222 💬
253Human Immunoglobulin----2件: 63, 65 💬
254Human immunoglobulin (pH4) for intravenous injection----1件: 63 💬
255HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G1件: Globulin, immune 💬 --4件: 14, 50, 63, 65 💬
256Human immunoglobulin intravenous----1件: 63 💬
257Human normal immunoglobulin----6件: 13, 14, 50, 51, 63, 65 💬
258HUMAN NORMAL IMMUNOGLOBULIN (IV)----4件: 11, 14, 63, 65 💬
259HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE----2件: 63, 65 💬
260HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE----1件: 63 💬
261Human normal immunoglobulin G (IgG > 98% purity)----3件: 14, 63, 65 💬
262HUMAX-CD38----2件: 28, 63 💬
263Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--29件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
264Hydroxychloroquine Oral Tablet1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--2件: 63, 66 💬
265Hypersialylated immunoglobulin----1件: 63 💬
266I10E----3件: 14, 63, 65 💬
267Ianalumab1件: Ianalumab1件: Ianalumab 💬 1件: TNFRSF13C 💬 5件: Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬8件: 35, 46, 49, 51, 53, 61, 63, 95 💬
268IanalumabProduct Code: VAY736Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: IanalumabCurrent Sponsor code: VAY736Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 150-Pharmaceutical form of the placebo: Concentrate for solution for infusionRoute of administration of the placebo: Intravenous use----2件: 61, 63 💬
269Ig VENA----2件: 50, 63 💬
270Ig VENA 100 ml vial----1件: 63 💬
271Ig VENA 50 g/l solution for infusion 100 ml vial + infusion set----2件: 63, 65 💬
272IgG Next Generation----2件: 63, 65 💬
273IGIV3I Grifols----1件: 63 💬
274IGIV3I Grifols 10%----1件: 63 💬
275IgNextGen 10%----1件: 63 💬
276IgPro10----4件: 14, 51, 63, 65 💬
277Iguratimod1件: Iguratimod1件: Iguratimod 💬 1件: NFKB1 💬 76件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬7件: 46, 49, 51, 53, 63, 271, 300 💬
278Immune Globulin Intravenous (human), 10%----3件: 14, 63, 65 💬
279Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution----1件: 63 💬
280Immunglobulin----1件: 63 💬
281Immunoglobulin----3件: 13, 14, 63 💬
282IMMUNOGLOBULIN G----9件: 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
283Immunoglobulin Intravenous (Human)----2件: 63, 65 💬
284IMMUNOGLOBULINA UMANA NORMALE----4件: 14, 51, 63, 65 💬
285Inactivated Trivalent Influenza vaccine----1件: 63 💬
286Inaticabtagene Autoleucel1件: Inaticabtagene Autoleucel---3件: 49, 61, 63 💬
287Inaticabtagene autoleucel Injection1件: Inaticabtagene Autoleucel---3件: 49, 61, 63 💬
288INCA000585----1件: 63 💬
289Interleukin 10----2件: 46, 63 💬
290Interleukin 2----9件: 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
291Intravenous Immunoglobulin----9件: 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
292Intravenous immunoglobulin (IVIg)----8件: 14, 17, 19, 63, 65, 85, 164, 296 💬
293Intravenous immunoglobulin (IVIG), 10% solution for infusion----2件: 2, 63 💬
294Intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---1件: 63 💬
295Intravenous immunoglobulins----1件: 63 💬
296Iptacopan1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬8件: 11, 61, 62, 63, 66, 109, 222, 223 💬
297Iptacopan hydrochloride1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬5件: 61, 63, 66, 109, 223 💬
298IVIG----8件: 11, 13, 14, 18, 51, 63, 65, 172 💬
299IVIG infusion----1件: 63 💬
300IVIG-L----1件: 63 💬
301JCXH-213----1件: 63 💬
302Kardégic----1件: 63 💬
303Kedrion IVIG 10%----2件: 63, 65 💬
304KZR-616----4件: 49, 50, 61, 63 💬
305L01FC01----1件: 63 💬
306Lansoprazole1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬8件: 63, 71, 85, 98, 166, 222, 223, 299 💬
307Lansoprazole, clarithromycin, amoxycillin2件: Clarithromycin,
Lansoprazole		2件: Clarithromycin ,
Lansoprazole 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 63 💬
308Levofloxacin1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--5件: 46, 53, 63, 84, 299 💬
309Levofloxacin-Based H. pylori Eradication Therapy1件: Levofloxacin2件: Levofloxacin ,
Levofloxacin 💬 		--1件: 63 💬
310LGD-4665----1件: 63 💬
311LIV-GAMMA SN Inj.----1件: 63 💬
312LIV-GAMMA SN Inj.10%----1件: 63 💬
313LNP023----7件: 61, 62, 63, 66, 109, 222, 223 💬
314Low-dose rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
315Luspatercept1件: Luspatercept1件: Luspatercept 💬 1件: ACVR2B 💬 4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬4件: 60, 61, 63, 282 💬
316Lusutrombopag1件: Lusutrombopag1件: Lusutrombopag 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
317Lusutrombopag Oral Tablet1件: Lusutrombopag1件: Lusutrombopag 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
318Lymphostat B----1件: 63 💬
319M254----1件: 63 💬
320Mabthera----20件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
321Mabthera®----7件: 13, 35, 43, 44, 46, 63, 93 💬
322Mabthéra----3件: 35, 63, 162 💬
323Medical Standard of Care for ITP----1件: 63 💬
324MENVEO – Polvere e soluzione per soluzione iniettabile----4件: 61, 62, 63, 223 💬
325Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
326Methylprednisolone and IVIG1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
327METILPREDNISOLONE----5件: 11, 53, 56, 63, 300 💬
328METRONIDAZOLE1件: Metronidazole2件: Metronidazole ,
Metronidazole hydrochloride 💬 		--7件: 46, 51, 63, 94, 96, 97, 291 💬
329Mezagitamab1件: Mezagitamab1件: Mezagitamab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 63, 66, 223 💬
330Mini-Pool IVIG----1件: 63 💬
331MK-8723----1件: 63 💬
332Montelukast1件: Montelukast2件: Montelukast sodium ,
Montelukast 💬 		1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬10件: 6, 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
333Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬38件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
334Mycophenolate Mofetil (MMF) Treatment1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 63 💬
335N.a.----11件: 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
336Nanogam----2件: 57, 63 💬
337Neofordex----1件: 63 💬
338Neofordex 40 mg comprimés----1件: 63 💬
339Neofordex®----1件: 63 💬
340NewGam----3件: 14, 63, 65 💬
341NGS----2件: 61, 63 💬
342Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --19件: 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
343Nicotinamide adenine dinucleotid/nicotinamide mononucleotide3件: Adenine,
Nicotinamide,
Nicotinamide Mononucleotide		2件: Adenine ,
Niacinamide 💬 		--1件: 63 💬
344Nicotinamide Mononucleotide2件: Nicotinamide,
Nicotinamide Mononucleotide		1件: Niacinamide 💬 --2件: 63, 97 💬
345Nimenrix----4件: 50, 61, 63, 223 💬
346Ninlaro----2件: 61, 63 💬
347Nplate----2件: 60, 63 💬
348NPLATE 500 microgramos polvo para solución inyectable----1件: 63 💬
349NVG-2089----2件: 14, 63 💬
350Obinutuzumab1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬6件: 43, 44, 49, 63, 222, 223 💬
351Obinutuzumab Injection [Gazyva]1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
352Octagam 10%----3件: 50, 63, 65 💬
353Octagam® 10%----1件: 63 💬
354OM336----2件: 61, 63 💬
355Open Label (Avatrombopag tablets)1件: Avatrombopag2件: Avatrombopag ,
Avatrombopag maleate 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
356Orelabrutinib1件: Orelabrutinib1件: Orelabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬5件: 13, 49, 53, 61, 63 💬
357Orelabrutinib( higher dose)1件: Orelabrutinib1件: Orelabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
358Orelabrutinib( lower dose)1件: Orelabrutinib1件: Orelabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
359Oseltamivir1件: Oseltamivir2件: Oseltamivir phosphate ,
Oseltamivir 💬 		--3件: 63, 97, 299 💬
360Other: Blood draw for future biomarker analysis----2件: 13, 63 💬
361Other: Blood sample----37件: 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
362Other: Blood Samples----13件: 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
363Other: drug therapy for ITP----1件: 63 💬
364Other: healthy controls----1件: 63 💬
365Other: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)----1件: 63 💬
366Other: peripheral blood and bone marrow withdrawal----1件: 63 💬
367Other: Spleen samples----1件: 63 💬
368PANZYGA----2件: 14, 63 💬
369PARACETAMOLO----10件: 2, 11, 14, 19, 28, 53, 61, 63, 300, 309 💬
370PF-06755347 intravenous healthy participant----1件: 63 💬
371PF-06755347 subcutaneous healthy participant----1件: 63 💬
372PF-06755347 subcutaneous ITP----1件: 63 💬
373PF-06835375----3件: 46, 49, 63 💬
374PG2----1件: 63 💬
375Pirtobrutinib1件: Pirtobrutinib1件: Pirtobrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 13, 63 💬
376Platelet Concentrate----1件: 63 💬
377PN20----1件: 63 💬
378PN20 treatment----1件: 63 💬
379Povetacicept1件: Povetacicept1件: Povetacicept 💬 1件: TNFRSF13B 💬 3件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬5件: 11, 61, 63, 66, 222 💬
380Prednisolon----11件: 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
381PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
382Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
383Prednisone (Cortancyl®)1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
384Prednisone (Cortancyl®) alone followed by monitoring and standard of care1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
385Prednisone acetate3件: Acetate,
Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
386Prednisone tablet1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 63 💬
387PRG-1801----2件: 63, 300 💬
388PRIVIGEN----6件: 11, 14, 51, 63, 65, 222 💬
389Privigen®----3件: 14, 63, 65 💬
390PRN1008----4件: 35, 61, 63, 300 💬
391PRN1008 100 mg tablet----1件: 63 💬
392PRN1008 300 mg tablet----1件: 63 💬
393PRN1008 400 mg tablet----1件: 63 💬
394Probiotic Agent----1件: 63 💬
395Proteína recombinante estimulante de la megacariopoyesis----1件: 63 💬
396Proton pump inhibitor 1 mg/kg/day in 2 divided doses 1 month----1件: 63 💬
397PRTX-1001件: PRTX-100---2件: 46, 63 💬
398PRTX-100 (Staphylococcal protein A)1件: PRTX-100---1件: 63 💬
399QL0911----1件: 63 💬
400QT-019C----5件: 11, 13, 49, 51, 63 💬
401Quality-of-life assessment----4件: 28, 34, 51, 63 💬
402R788----2件: 46, 63 💬
403R935788----4件: 46, 61, 63, 66 💬
404Rapamycin1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 52件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬13件: 2, 15, 49, 51, 53, 60, 63, 67, 96, 158, 256, 278, 279 💬
405RAY121----4件: 48, 50, 63, 162 💬
406Recombinant Human Thrombopoietin2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---2件: 60, 63 💬
407Recombinant human thrombopoietin (rh-TPO)2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---1件: 63 💬
408Recombinant Human Thrombopoietin (rhTPO)2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---1件: 63 💬
409Recombinant Human Thrombopoietin(rhTPO)2件: Recombinant Human Thrombopoietin,
Thrombopoietin		---1件: 63 💬
410Recombinant Human TPO----1件: 63 💬
411Relovade----1件: 63 💬
412REVOLADE----2件: 60, 63 💬
413Revolade 25 mg film-coated tablets----1件: 63 💬
414Revolade 50 mg film-coated tablets----1件: 63 💬
415REVOLADE*28CPR RIV 25MG----1件: 63 💬
416REVOLADE, PROMACTA----1件: 63 💬
417RhIL-11----2件: 63, 97 💬
418Rho(D) Immune Globulin----1件: 63 💬
419RhTPO----2件: 60, 63 💬
420RhTPO in combination with Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 63 💬
421Rilzabrutinib1件: Rilzabrutinib1件: Rilzabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬6件: 35, 61, 63, 222, 223, 300 💬
422Ripertamab1件: Ripertamab---4件: 11, 14, 63, 222 💬
423Rituxan----5件: 46, 60, 63, 256, 288 💬
424Rituxan, Cyclophosphamide, Vincristine, Prednisone3件: Cyclophosphamide,
Prednisone,
Vincristine		5件: Cyclophosphamide ,
Prednisone ,
Vincristine sulfate ,
Cyclophosphamide ,
Vincristine 💬 		10件: NR3C1,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		13件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 63 💬
425RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
426Rituximab (Arm B)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 43, 44, 63 💬
427Rituximab (Mabthera ®) Belimumab (Benlysta ®)2件: Belimumab,
Rituximab		2件: Rituximab ,
Belimumab 💬 		2件: MS4A1,
TNFSF13B 💬 		5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 63 💬
428Rituximab (Mabthera)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 14, 63 💬
429Rituximab (MABTHERA® or RITUXAN®).1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 35, 61, 63 💬
430Rituximab [MabThera/Rituxan]1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 46, 63 💬
431Rituximab and dexamethasone2件: Dexamethasone,
Rituximab		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Rituximab ,
Dexamethasone phosphate 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
432Rituximab combined with Daratumumab(Anti-CD38 Monoclonal Antibody)2件: Daratumumab,
Rituximab		2件: Rituximab ,
Daratumumab 💬 		2件: CD38,
MS4A1 💬 		6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 63 💬
433Rituximab plus methylprednisolone2件: Methylprednisolone,
Rituximab		3件: Methylprednisolone ,
Methylprednisolone acetate ,
Rituximab 💬 		2件: MS4A1,
NR3C1 💬 		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63 💬
434Rocaltrol----1件: 63 💬
435Romiplostim1件: Romiplostim1件: Romiplostim 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬4件: 60, 63, 64, 65 💬
436Romiplostim and danazol2件: Danazol,
Romiplostim		2件: Danazol ,
Romiplostim 💬 		4件: AR,
ESR1,
MPL,
PGR 💬 		14件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, Hormone signaling, JAK-STAT signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 63 💬
437Romiplostim N011件: Romiplostim1件: Romiplostim 💬 1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬2件: 60, 63 💬
438Romiplostim N01 combined with dexamethasone2件: Dexamethasone,
Romiplostim		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		2件: MPL,
NR3C1 💬 		4件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63 💬
439Romiplostim plus dexamethasone2件: Dexamethasone,
Romiplostim		4件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Romiplostim 💬 		2件: MPL,
NR3C1 💬 		4件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63 💬
440Romiplostin----1件: 63 💬
441Ropivacaine1件: Ropivacaine2件: Ropivacaine hydrochloride ,
Ropivacaine 💬 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN8A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬7件: 22, 36, 46, 63, 70, 71, 97 💬
442ROZANOLIXIZUMAB1件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
443RozanolixizumabProduct Code: UCB7665Pharmaceutical Form: Solution for infusionINN or Proposed INN: ROZANOLIXIZUMABCAS Number: 1584645-37-3Current Sponsor code: UCB7665Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 140-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Subcutaneous use----1件: 63 💬
444S-888711----1件: 63 💬
445SAR444671----3件: 61, 63, 300 💬
446SAR445088 (BIVV020)----1件: 63 💬
447SB-497115----1件: 63 💬
448SB-497115-GR----1件: 63 💬
449SB-497115-GR 12.5mg----1件: 63 💬
450SB-497115-GR 25mg----1件: 63 💬
451SB-497115-GR 50 mg----1件: 63 💬
452SB497115----2件: 60, 63 💬
453Second Line ITP agents----1件: 63 💬
454SHR-2173 injection----5件: 11, 49, 63, 66, 222 💬
455Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 52件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬46件: 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
456Sitagliptin1件: Sitagliptin3件: Sitagliptin phosphate ,
Sitagliptin ,
Sitagliptin phosphate 💬 		1件: DPP4 💬 2件: Protein digestion and absorption, Virion - Hepatitis viruses 💬6件: 6, 63, 75, 77, 233, 299 💬
457SKI-O-703----2件: 46, 63 💬
458SM101----3件: 49, 63, 66 💬
459SM101 20mg/mL----1件: 63 💬
460SM101 5mg/mL----1件: 63 💬
461Spleen sample----2件: 61, 63 💬
462Standard of Care----18件: 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
463Standard therapy (without eltrombopag): HD-DXM1件: Eltrombopag2件: Eltrombopag olamine ,
Eltrombopag choline 💬 		1件: MPL 💬 3件: Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬1件: 63 💬
464Steroid and eltrombopage----1件: 63 💬
465Steroids----7件: 46, 50, 51, 63, 66, 96, 97 💬
466STSA-1301 subcutaneous injection----1件: 63 💬
467Sym001----1件: 63 💬
468T cell injection targeting CD19 chimeric antigen receptor----7件: 46, 49, 51, 53, 63, 93, 300 💬
469Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬37件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
470TAK-079----3件: 11, 49, 63 💬
471Telitacicept1件: Telitacicept---14件: 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
472Terbutaline1件: Terbutaline2件: Terbutaline sulfate ,
Terbutaline 💬 		1件: ADRB2 💬 11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 63, 118 💬
473TERIFLUNOMIDE1件: Teriflunomide1件: Teriflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬4件: 13, 25, 26, 63 💬
474Thalidomide1件: Thalidomide1件: Thalidomide 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬22件: 2, 16, 20, 28, 49, 51, 53, 56, 63, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
475The best available therapy----1件: 63 💬
476Thrombopoietin1件: Thrombopoietin---4件: 47, 60, 61, 63 💬
477Thrombopoietin Receptor Agonist1件: Thrombopoietin---3件: 60, 61, 63 💬
478Thrombopoietin receptor agonist (TPO-RA)1件: Thrombopoietin---3件: 60, 61, 63 💬
479TPO----1件: 63 💬
480TPO-RA----1件: 63 💬
481Tpo-RA discontinuation----1件: 63 💬
482TPO-RAs----1件: 63 💬
483TPO-RAs combining anti-CD 20 monoclonal antibody----1件: 63 💬
484TQB3473 Tablets----1件: 63 💬
485Treatment : H. pylori eradication----1件: 63 💬
486Tretinoin1件: Tretinoin1件: Tretinoin 💬 3件: PML,
RARA,
RARB 💬 		12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬4件: 2, 62, 63, 75 💬
487Triple therapy----2件: 50, 63 💬
488TYSABRI----3件: 13, 25, 63 💬
489UCB76651件: Rozanolixizumab1件: Rozanolixizumab 💬 --3件: 11, 14, 63 💬
490Universal STAR-T Cell----1件: 63 💬
491Upadacitinib1件: Upadacitinib3件: Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		1件: JAK1 💬 27件: Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
492Urine sample----5件: 49, 51, 61, 63, 84 💬
493VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B----5件: 61, 62, 63, 66, 223 💬
494VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO----5件: 61, 62, 63, 66, 223 💬
495VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135)----5件: 61, 62, 63, 66, 223 💬
496VAY736----9件: 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
497Veltuzumab1件: Veltuzumab1件: Veltuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 46, 63 💬
498Vinblastine1件: Vinblastine2件: Vinblastine sulfate ,
Vinblastine 💬 		9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬3件: 34, 63, 65 💬
499Vincristine1件: Vincristine2件: Vincristine sulfate ,
Vincristine 💬 		9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬5件: 26, 34, 63, 65, 331 💬
500VIT D----2件: 63, 227 💬
501Vonoprazan1件: Vonoprazan1件: Vonoprazan 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬3件: 63, 97, 98 💬
502Water1件: Water1件: Water 💬 --36件: 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
503YTS109 cell injection----2件: 49, 63 💬
504Zanubrutinib1件: Zanubrutinib1件: Zanubrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬7件: 13, 48, 61, 63, 222, 300, 331 💬
505Zanubrutinib 160mg/d1件: Zanubrutinib1件: Zanubrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
506Zanubrutinib 240mg/d1件: Zanubrutinib1件: Zanubrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
507Zanubrutinib 80mg/d1件: Zanubrutinib1件: Zanubrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 63 💬
508ZUBERITAMAB1件: ZUBERITAMAB---2件: 63, 222 💬
509 LNP023 HYDROCHLORIDE SALT----7件: 61, 62, 63, 66, 109, 222, 223 💬